Personal Information
Professor Supervisor of Doctorate Candidates Supervisor of Master's Candidates
Paper Publications
- [1] Xiao, Shichao.Yin, Hang,Lv, Xin,Wang, Zhen,Lili Jiang,Xia, Yangliu,Liu Yong,Liu, Yong; Xia, Yangliu.Efficacy and safety of androgen receptor inhibitors for treatment of advanced prostate cancer: A systematic review and network meta-analysis[J],BRITISH JOURNAL OF CLINICAL PHARMACOLOGY,2024,90(9):2067-2078
- [2] Zhang, Nan.Liu Yong,Jeong, Hyunyoung.Drug-Drug Interaction Potentials of Tyrosine Kinase Inhibitors via Inhibition of UDP-Glucuronosyltransferases[J],Scientific Reports,2022,5:17778
- [3] Lili Jiang.Chen, Daoyu,Wang, Zhen,Zhang, Zhongmin,夏杨柳,薛宏宇,Liu Yong.Preparation of an Electrically Conductive Graphene Oxide/Chitosan Scaffold for Cardiac Tissue Engineering[J],APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY,2022,188(4):952-964
- [4] Lili Jiang.Liu Yong,Wang, Zhe,Lv, Xin,Yin, Hang.范晓宇,贾艳艳,王潇宇,贾雅钦,冯钰益,阎明睿.Insights into efficacy and safety of dapagliflozin treatment for the management in older adults with type 2 diabetes: a systematic review and meta-analysis[J],EXPERT OPINION ON DRUG SAFETY,2023,22(5):407-416
- [5] Lv, Xin.Wang, Zhe,Yin, Hang,夏杨柳,Lili Jiang,Liu Yong.王珍.Inhibition of human UDP-glucuronosyltransferase enzyme by ripretinib: Implications for drug-drug interactions[J],TOXICOLOGY AND APPLIED PHARMACOLOGY,2023,466
- [6] Wang, Zhen.Lili Jiang,Lv, Xin,Yin, Hang,Wang, Zhe,李文利,Liu Yong.Higher risk of hepatotoxicity associated with cabozantinib in cancer patients[J],CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY,2024,196
- [7] Ye, Weiyi.Wang, Zhen,Lv, Xin,Yin, Hang,Lili Jiang,Wang, Zhe,Liu Yong.Potential risk of drug-drug interactions of ponatinib via inhibition against human UDP-glucuronosyltransferases[J],TOXICOLOGY IN VITRO,2023,92
- [8] Du, Jie.Liu, Jing,Wang, Shujuan,Wang, Changyuan,Meng, Qiang,Sun, Huijun,Liu, Kexin,Liu Yong,Wu, Jingjing.Characterization of Dicaffeoylspermidine Derivatives from Wolfberry as Potent and Selective Inhibitors of Human Cytochrome P450 46A1 In vitro[J],CURRENT DRUG METABOLISM,2023,24(2):124-130
- [9] 吕新.Wang, Zhe,夏杨柳,Lili Jiang,Liu Yong,Jiang, Lili; Liu.王珍,尹航.Avapritinib Carries the Risk of Drug Interaction via Inhibition of UDP-Glucuronyltransferase (UGT) 1A1[J],CURRENT DRUG METABOLISM,2024,25(3):197-204
- [10] Lv, Xin.Wang, Zhe,Wang, Zhen,Yin, Hang,夏杨柳,Lili Jiang,Liu Yong.Drug-drug interaction potentials of tucatinib inhibition of human UDP-glucuronosyltransferases[J],CHEMICO-BIOLOGICAL INTERACTIONS,2023,381